Free Trial

Indaptus Therapeutics (INDP) News Today

Indaptus Therapeutics logo
$0.91 +0.02 (+2.26%)
(As of 12/24/2024 02:21 PM ET)
Indaptus Therapeutics files to sell 1.94M shares of common stock for holders
Indaptus Therapeutics price target lowered to $5 from $8 at Maxim
Indaptus Therapeutics announces clinical supply agreement with BeiGene
Armaguard rebuffs $26m cash lifeline
Indaptus Dives on Quarterly Results
Indaptus Therapeutics: Q4 Earnings Insights
Get Indaptus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for INDP and its competitors with MarketBeat's FREE daily newsletter.

After New Years, price goes back up 4,800% (Ad)

When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!

Click here to review Tim’s special Holiday offer before it’s too late.

INDP Media Mentions By Week

INDP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INDP
News Sentiment

0.59

0.57

Average
Medical
News Sentiment

INDP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INDP Articles
This Week

2

0

INDP Articles
Average Week

Get Indaptus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for INDP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:INDP) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners